The extremist campaign against animal research moved to a new level on Monday when private GlaxoSmithKline shareholders received threatening letters, demanding they sell their shares within 14 days or face public exposure. Campaigners have not previously targeted individual investors in a multinational company.
The unsigned letters - from a previously unknown group called Campaign against Huntingdon Life Sciences - reached shareholders in yesterday's post. GSK said about 50 worried recipients, mainly elderly people, contacted the company but it had no way of knowing how many of its 167,000 registered shareholders would receive them. Many were likely to find letters on the doormat when they got home from work
June 2005 July 2005 August 2005 September 2005 October 2005 November 2005 December 2005 January 2006 February 2006 March 2006 April 2006 May 2006 June 2006 August 2006 September 2006 October 2007 November 2007 December 2007 January 2008 March 2008 May 2008 January 2009 February 2009 July 2009 November 2009 December 2009 January 2010 April 2010 September 2010 October 2010 November 2010 February 2011 March 2011 April 2011 August 2011 September 2011
Subscribe to Posts [Atom]